Psyence Biomedical Ltd. (PBM) stock
PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW
$4.12−0.10 (-2.37%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Psyence Biomedical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Psyence Biomedical
Psyence Biomedical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?